FTB Advisors Inc. cut its position in Stericycle Inc. (NASDAQ:SRCL) by 74.2% during the second quarter, Holdings Channel reports. The institutional investor owned 1,219 shares of the company’s stock after selling 3,501 shares during the period. FTB Advisors Inc.’s holdings in Stericycle were worth $127,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the company. Kornitzer Capital Management Inc. KS raised its position in shares of Stericycle by 16.9% in the second quarter. Kornitzer Capital Management Inc. KS now owns 243,625 shares of the company’s stock worth $25,366,000 after buying an additional 35,200 shares in the last quarter. Moody Lynn & Lieberson LLC purchased a new position in Stericycle during the second quarter worth about $857,000. Nordea Investment Management AB boosted its position in Stericycle by 38.5% in the second quarter. Nordea Investment Management AB now owns 38,899 shares of the company’s stock worth $4,050,000 after buying an additional 10,810 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD boosted its position in Stericycle by 2.3% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 6,316 shares of the company’s stock worth $657,000 after buying an additional 143 shares during the last quarter. Finally, Hedeker Wealth LLC purchased a new position in Stericycle during the second quarter worth about $512,000. Institutional investors and hedge funds own 92.76% of the company’s stock.
Stericycle Inc. (NASDAQ:SRCL) traded up 0.27% during midday trading on Wednesday, reaching $75.05. The company’s stock had a trading volume of 656,699 shares. Stericycle Inc. has a 12-month low of $72.89 and a 12-month high of $150.96. The company’s 50-day moving average is $79.63 and its 200 day moving average is $96.53. The firm has a market cap of $6.38 billion, a price-to-earnings ratio of 26.42 and a beta of 0.20.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.18. The business had revenue of $891.60 million for the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business’s quarterly revenue was up 24.6% on a year-over-year basis. During the same period last year, the firm earned $1.14 earnings per share. Equities analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current year.
A number of research firms have recently issued reports on SRCL. Zacks Investment Research cut Stericycle from a “hold” rating to a “sell” rating in a report on Tuesday, June 28th. Jefferies Group reiterated a “buy” rating and issued a $140.00 price objective on shares of Stericycle in a report on Monday, July 18th. Wellington Shields cut Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Imperial Capital cut Stericycle from an “in-line” rating to an “underperform” rating and cut their price objective for the stock from $100.00 to $93.50 in a report on Friday, July 29th. Finally, Barrington Research reiterated an “outperform” rating and issued a $88.00 price objective (down from $100.00) on shares of Stericycle in a report on Wednesday, October 5th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $103.54.
In other news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.